Cargando…

Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis

BACKGROUND/AIMS: It is well known that 5-aminosalicylic acid (5-ASA) is the standard first-line treatment for ulcerative colitis (UC). Medication adherence is an important factor in the treatment of UC. We aimed to identify predictors of low adherence to oral 5-ASA in Koreans with UC. METHODS: Betwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jin, Jee, Sam Ryong, Kim, Hyung Wook, Baek, Dong Hoon, Song, Geun Am, Moon, Won, Park, Seun Ja, Kim, Hyun Jin, Lee, Jong Hoon, Park, Jong Ha, Kim, Tae Oh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430391/ https://www.ncbi.nlm.nih.gov/pubmed/30901362 http://dx.doi.org/10.1371/journal.pone.0214129

Ejemplares similares

Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis
por: Tripathi, Kartikeya, et al.
Publicado: (2021)

Predictive Factors for Severe Outcomes in Ischemic Colitis
por: Choi, Seok Reyol, et al.
Publicado: (2015)

Clinical features of Crohn's disease in Korean patients residing in Busan and Gyeongnam
por: Lee, Eun Ji, et al.
Publicado: (2016)

Clinical Efficacy of Probiotic Therapy on Bowel-Related Symptoms in Patients with Ulcerative Colitis during Endoscopic Remission: An Observational Study
por: Lee, Jin, et al.
Publicado: (2022)

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
por: Park, Soo-Kyung, et al.
Publicado: (2022)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
por: Miyoshi, Jun, et al.
Publicado: (2018)

Duodenal amyloidosis secondary to ulcerative colitis
por: Park, Seung Woon, et al.
Publicado: (2018)

Efficacy of sigmoidoscopy for evaluating disease activity in patients with ulcerative colitis
por: Park, Su Bum, et al.
Publicado: (2022)

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates
por: Freeman, Hugh James
Publicado: (2012)

The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
por: He, Long, et al.
Publicado: (2021)

Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis
por: Mikami, Yohei, et al.
Publicado: (2023)

5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
por: Xu, Jun, et al.
Publicado: (2018)

Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2019)

Postoperative changes of manometry after restorative proctocolectomy in Korean ulcerative colitis patients
por: Oh, Se Heon, et al.
Publicado: (2017)

Adherence to 5-aminosalicylic acid maintenance treatment in young people with ulcerative colitis: a retrospective cohort study in primary care
por: Jayasooriya, Nishani, et al.
Publicado: (2023)

Development of Pseudomembranous Colitis Four Months after Initiation of Rifampicin
por: Choi, Jeong Moon, et al.
Publicado: (2011)

Colon-targeting mutual prodrugs of 5-aminosalicylic acid and butyrate for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2018)

5-Aminosalicylates Reduce the Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis: An Updated Meta-Analysis
por: Zhao, Li-Na, et al.
Publicado: (2014)

A New Chinese Medicine Intestine Formula Greatly Improves the Effect of Aminosalicylate on Ulcerative Colitis
por: Liu, Baohai, et al.
Publicado: (2017)

Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis
por: Uchiyama, Kazuhiko, et al.
Publicado: (2023)

Hyaluronic Acid-Conjugated PLGA Nanoparticles Alleviate Ulcerative Colitis via CD44-Mediated Dual Targeting to Inflamed Colitis Tissue and Macrophages
por: Hlaing, Shwe Phyu, et al.
Publicado: (2022)

Periodontitis combined with smoking increases risk of the ulcerative colitis: A national cohort study
por: Kang, Eun Ae, et al.
Publicado: (2020)

Clinical course of ulcerative colitis patients who develop acute pancreatitis
por: Kim, Jong Wook, et al.
Publicado: (2017)

Is the Long-term Disease Course of Elderly-Onset Ulcerative Colitis Different from That of Non-Elderly-Onset Ulcerative Colitis?
por: Lee, Jin Wook, et al.
Publicado: (2021)

Conjugation of Amisulpride, an Anti-Psychotic Agent, with 5-Aminosalicylic Acid via an Azo Bond Yields an Orally Active Mutual Prodrug against Rat Colitis
por: Kim, Wooseong, et al.
Publicado: (2019)

Comparison of sampling methods in assessing the microbiome from patients with ulcerative colitis
por: Kim, Dan, et al.
Publicado: (2021)

Short-term Outcomes of Elective 2-Stage Restorative Proctocolectomy for Ulcerative Colitis in Korea: Does Laparoscopy Have Benefits?
por: Bong, Jun Woo, et al.
Publicado: (2020)

Ulcerative Colitis Impairs the Acylethanolamide-Based Anti-Inflammatory System Reversal by 5-Aminosalicylic Acid and Glucocorticoids
por: Suárez, Juan, et al.
Publicado: (2012)

Combination of Azathioprine and Aminosalicylate Treatment Prevent Risk of Cardiovascular Disease in Women with Ulcerative Colitis by Reducing Inflammation
por: dos Santos, Lana Claudinez, et al.
Publicado: (2015)

Comparison of maintenance effect of probiotics and aminosalicylates on ulcerative colitis: A meta-analysis of randomized controlled trials
por: Jiang, Yong, et al.
Publicado: (2016)

Mucosal 5‐aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis
por: Olaisen, Maya, et al.
Publicado: (2019)

Therapeutic Efficacy of the Combination Therapy of Corticosteroids and 5-Aminosalicylic Acid for Treatment of Pyoderma Gangrenosum with Ulcerative Colitis
por: Chen, Wei, et al.
Publicado: (2020)

Comparison of effects of aminosalicylic acid, glucocorticoids and immunosuppressive agents on the expression of multidrug-resistant genes in ulcerative colitis
por: Chen, Yan, et al.
Publicado: (2022)

Coexistence of Solitary Rectal Ulcer Syndrome and Ulcerative Colitis: A Case Report and Literature Review
por: Park, Hyun Bum, et al.
Publicado: (2014)

Diagnosis of Crohn’s disease and ulcerative colitis using the microbiome
por: Kang, Da-Yeon, et al.
Publicado: (2023)

Fecal microbiota transplantation treatment for refractory ulcerative colitis with allergy to 5-aminosalicylic acid: A case report
por: Wang, Hong-Gang, et al.
Publicado: (2018)

Probiotics combined with aminosalicylic acid affiliates remission of ulcerative colitis: a meta-analysis of randomized controlled trial
por: Peng, Lijun, et al.
Publicado: (2019)

5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis
por: Mizuno, Shinta, et al.
Publicado: (2020)

Mucosal concentrations of N‐acetyl‐5‐aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine
por: Fukuda, Tomohiro, et al.
Publicado: (2020)

Assessment of disease activity by fecal immunochemical test in ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a3ak2jjf22m6fore74nl8fcdjv